Facebook
Twitter
Telegram
Report an ErrorMonopar Therapeutics Financial Statements 2011-2024 | MNPR
Annual Financial Statements Monopar Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
9.4 M | 35.6 M | 38.5 M | 93.9 M | 157 M | - | - | - | - | - | - | - | - |
Shares |
13.8 M | 12.7 M | 12.5 M | 11.1 M | 9.32 M | - | - | - | - | - | - | - | - |
Historical Prices |
0.68 | 2.8 | 3.09 | 7.3 | 9.6 | - | - | - | - | - | - | - | - |
Net Income |
-8.4 M | -10.5 M | -9.1 M | -6.3 M | -4.22 M | -3.23 M | -16.6 M | -1.19 M | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-8.83 M | -10.5 M | -9.13 M | -6.51 M | -4.32 M | -3.33 M | -16.6 M | -1.19 M | - | - | - | - | - |
Interest Expense |
429 K | 21.2 K | 24 K | 81.9 K | 98.9 K | 103 K | 48.3 K | 7.23 K | - | - | - | - | - |
EBITDA |
-8.83 M | -10.5 M | -9.13 M | -6.63 M | -4.32 M | -3.4 M | -16.6 M | -1.19 M | - | - | - | - | - |
Operating Expenses |
8.83 M | 10.5 M | 9.13 M | 6.51 M | 4.32 M | 3.4 M | 16.6 M | - | - | - | - | - | - |
General and Administrative Expenses |
3.23 M | 2.95 M | 2.63 M | 2.44 M | 2.36 M | 1.63 M | 1.17 M | 912 K | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Monopar Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
14.1 M | 13.4 M | 13.2 M | 12.9 M | 12.8 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12.1 M | 11.5 M | 11.1 M | 10.6 M | 10.6 M | 10.6 M | 9.29 M | 9.29 M | 9.29 M | 9.29 M | 9.29 M | 9.29 M | 9.29 M | 9.29 M | 8.87 M | 8.62 M | 8.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-1.95 M | -2.2 M | -2.43 M | - | -2.4 M | -2.76 M | -2.46 M | - | -2.46 M | -2.08 M | -1.88 M | - | -1.64 M | -1.45 M | -1.09 M | - | -736 K | -906 K | -1.38 M | -890 K | -640 K | -890 K | -890 K | - | -14.9 M | -591 K | -373 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.07 M | -2.33 M | -2.53 M | - | -2.41 M | -2.76 M | -2.46 M | - | -2.46 M | -2.09 M | -1.89 M | - | -1.65 M | -1.46 M | -1.14 M | - | -759 K | -932 K | -1.41 M | - | -668 K | -668 K | -897 K | - | -14.9 M | -595 K | -374 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
112 K | 128 K | 90.5 K | - | 7.7 K | 417 | 464 | - | 577 | 12.2 K | 10.7 K | - | 8.54 K | 18.3 K | 45.1 K | - | 23.4 K | 26.4 K | 31.1 K | - | 27.3 K | 27.3 K | 20.9 K | - | 20.6 K | 3.52 K | 924 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-2.07 M | -2.33 M | -2.53 M | - | -2.41 M | -2.76 M | -2.46 M | - | -2.46 M | -2.09 M | -1.89 M | - | -1.65 M | -1.46 M | -1.14 M | - | -759 K | -932 K | -1.41 M | - | -668 K | -668 K | -897 K | - | -14.9 M | -595 K | -374 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
2.07 M | 2.33 M | 2.53 M | - | 2.41 M | 2.76 M | 2.46 M | - | 2.46 M | 2.09 M | 1.89 M | - | 1.65 M | 1.46 M | 1.14 M | - | 759 K | 932 K | 1.41 M | - | 668 K | 668 K | 897 K | - | 14.9 M | 595 K | 374 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
749 K | 733 K | 872 K | - | 675 K | 685 K | 779 K | - | 632 K | 616 K | 688 K | - | 392 K | 632 K | 792 K | - | 540 K | 603 K | 572 K | - | 364 K | 364 K | 440 K | - | 215 K | 283 K | 240 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency